Key Details
Price
$17.74Last Dividend
$0.10Annual ROE
-15.37%Beta
0.78Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Feb 29, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Dec 02, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
NEW YORK, NY / ACCESS Newswire / January 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Pactiv Evergreen Inc. ("Pactiv Evergreen") (NASDAQ:PTVE) and Novolex®. Investors who purchased Pactiv Evergreen and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTVE.
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Pactiv Evergreen Inc. ("Pactiv Evergreen") (NASDAQ:PTVE) and Novolex®. Investors who purchased Pactiv Evergreen and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTVE.
NEW YORK, NY / ACCESSWIRE / January 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Pactiv Evergreen Inc. ("Pactiv Evergreen") (NASDAQ:PTVE) and Novolex®. Investors who purchased Pactiv Evergreen and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTVE.
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Pactiv Evergreen Inc. ("Pactiv Evergreen") (NASDAQ:PTVE) and Novolex®. Investors who purchased Pactiv Evergreen and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTVE.
NEW YORK, NY / ACCESSWIRE / December 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Pactiv Evergreen Inc. ("Pactiv Evergreen") (NASDAQ:PTVE) and Novolex®. Investors who purchased Pactiv Evergreen and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTVE.
NEW YORK, NY / ACCESSWIRE / December 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Pactiv Evergreen Inc. ("Pactiv Evergreen") (NASDAQ:PTVE) and Novolex®. Investors who purchased Pactiv Evergreen and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTVE.
PHILADELPHIA, PA / ACCESSWIRE / December 20, 2024 / Kaskela Law LLC announces that it has commenced an investigation into Pactiv Evergreen Inc. (NASDAQ:PTVE) ("Pactiv") on behalf of the company's current shareholders. Additional information: https://kaskelalaw.com/case/pactiv-evergreen/ On December 9, 2024, Pactiv announced that it had agreed to be acquired by Novolex at a price of $18.00 per share in cash.
NEW YORK, NY / ACCESSWIRE / December 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Pactiv Evergreen Inc. ("Pactiv Evergreen") (NASDAQ:PTVE) and Novolex®. Investors who purchased Pactiv Evergreen and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTVE.
NEW YORK, NY / ACCESSWIRE / December 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Pactiv Evergreen Inc. ("Pactiv Evergreen") (NASDAQ:PTVE) and Novolex®. Investors who purchased Pactiv Evergreen and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTVE.
Pactiv Evergreen Inc. (PTVE) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, PTVE's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
FAQ
- What is the primary business of Pactiv Evergreen?
- What is the ticker symbol for Pactiv Evergreen?
- Does Pactiv Evergreen pay dividends?
- What sector is Pactiv Evergreen in?
- What industry is Pactiv Evergreen in?
- What country is Pactiv Evergreen based in?
- When did Pactiv Evergreen go public?
- Is Pactiv Evergreen in the S&P 500?
- Is Pactiv Evergreen in the NASDAQ 100?
- Is Pactiv Evergreen in the Dow Jones?
- When was Pactiv Evergreen's last earnings report?
- When does Pactiv Evergreen report earnings?
- Should I buy Pactiv Evergreen stock now?